Genmab A/S Stock

Genmab A/S Buyback Yield

The Buyback Yield of Genmab A/S (GMAB.CO) as of Aug 11, 2026 is 2.43 %. In the previous year, Buyback Yield was 3.25 % — a change of -25.17% (lower).

Buyback Yield

2.43 %

YoY

-25.17%

Last updated:

Buyback Yield of Genmab A/S is 2026 2.43 % . Buyback Yield of Genmab A/S was 2025 3.25 % . It decreases by -25.17% lower compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Buyback Yield of Genmab A/S is 2.43 % in 2026.

Buyback Yield of Genmab A/S changed from 3.25 % to 2.43 %, representing a -25.17% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Buyback Yield Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

Buyback yield measures the percentage of market cap returned to shareholders through share repurchases. It complements dividend yield in assessing total shareholder returns.

To evaluate Buyback Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Buyback Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Buyback Yield's Genmab A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Genmab A/S

All Key Metrics — Genmab A/S